Nutrien exceeded analysts’ profit expectations for the third quarter and announced a strategic review of its phosphate business. Shares of the Canadian company, listed in the U.S., increased by 1.8% following the news. The review aims to explore options like reconfiguring operations, forming strategic partnerships, or a potential sale, as part of Nutrien’s strategy to streamline its portfolio and enhance free cash flow.
In 2025, phosphate markets have been constrained by limited global shipments, impacted by Chinese export restrictions, while reduced affordability has affected demand. Conversely, a strong planting season and healthy crop yields in parts of North America, along with lower prices, have driven up demand for potash fertilizers. Nutrien, the leading potash producer globally, reported total sales of $6.01 billion for the third quarter, an increase from $5.35 billion the previous year.
Potash sales surged by 27% to $1.12 billion, and phosphate sales rose by 20% to $495 million during the July-September timeframe. The company, headquartered in Saskatoon, Canada, recorded an adjusted profit of 97 cents per share for the quarter ending September 30, surpassing the average analyst estimate of 95 cents per share.
